Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2004) 8 P60

SFE2004 Poster Presentations Growth and development (8 abstracts)

Urokinase-type plasminogen activator: a novel ligand for anosmin-1, the protein implicated in X-linked Kallmann's syndrome

Youli Hu , David Gonzalez-Martinez , Soo-Hyun Kim & Pierre Bouloux

Neuroendocrine Unit, Royal Free and University College Medical School. UCL.

Introduction: Loss of anosmin-1 function underlies the pathogenesis of X-linked Kallmann's syndrome (X-KS), a disorder characterized by anosmia (loss of smell) and hypogonadotrophic hypogonadism, due to olfactory bulb (OB) dysgenesis and failed migration of gonadotrophin releasing hormone (GnRH) neurons. Additional phenotypic features include bimanual synkinesis and unilateral renal agenesis. Anosmin-1 contains a whey acidic protein-like (WAP) domain and four contiguous fibronectin-like type III (FnIII) repeats; its WAP domain contains eight highly conserved cysteine residues forming four intramolecular disulphide bonds. This four-disulphide core motif is common to WAP protein family mermbers, which generally function as serine protease inhibitors. Anosmin-1 and urokinase-type plasminogen activator (uPA) expression is detected in developing OB. Furthermore, uPA has been reported to influence cell proliferation, tissue remodelling, and neurite outgrowth. In this study, uPA was thus investigated as a putative serine protease candidate ligand for anosmin-1.


The effect of anosmin-1 on thrombin and uPA amidolytic activity was investigated using a specific chromogenic substrate. The direct binding of anosmin-1 to uPA and their kinetic interactions were investigated by surface plasmon resonance (SPR). The functional consequences of co-operation of anosmin-1/uPA were investigated on PC-3 cell proliferation. Co-immunoprecipitation was performed in PC-3 cell lysates.


Anosmin-1 unexpectedly and significantly enhanced uPA amidolytic activity, but was without effect on thrombin. Direct high affinity binding of these molecules (Kd = 6.91 nM) was demonstrated by SPR. In PC-3 cells, anosmin-1/uPA cooperation induced cell proliferation, and complex formation between these two proteins was demonstrated by co-immunoprecipitation from PC-3 cell lysates.


uPA constitutes a novel ligand for anosmin-1. Together with previous observations that C-terminal FnIII domain of anosmin-1 binds to heparan sulphate with a high affinity (Kd = 2nM), we can propose that anosmin-1 modulates uPA's catalytic activity and its signaling pathway, whereas HS determines cell surface localization of the anosmin-1/uPA complex.

Volume 8

195th Meeting of the Society for Endocrinology joint with Diabetes UK and the Growth Factor Group

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.